Table 2. Baseline characteristics of CV-risk patient cohorts.
| CV-risk patients | ADEDLAHYDE | R2C2 | BIOMARCOEURS | IBLOMAVED | REVE | GECOH | HVC |
| Number of patients | 378 | 169 | 1117 | 502 | 512 | 266 | 1880 |
| Women, No. (%) | 205 (54) | 87 (51.5) | 473 (42.3) | 156 (31.1) | 113 (22.1) | 162 (60.9) | 961 (51.1) |
| Age, years | 70±6 | 55±6 | 71±16 | 60±13 | 58±14 | 50±17 | 58±15 |
| Body mass index, kg/m2 | 28.0±4.3 | 28.8±5.3 | 26.6±6.2 | 27.0±5.4 | 27.1±4.7 | 28.7±6.3 | 27.3±5.4 |
| Weight, kg | 76.1±14.0 | 80.7±16.4 | 74.4±18.3 | 77.2±18.1 | 78.5±15.1 | 82.9±19.0 | 79.4±17.4 |
| Height, cm | 165±9 | 167±9 | 167±9 | 169±9 | 170±8 | 170±9 | 170±10 |
| Smokers, No. (%) | 30 (7.9) | 24 (14) | 261 (23) | 67 (14) | 238 (47) | 29 (11) | 362 (19) |
| Consume alcohol, No. (%) | 258 (68) | 125 (74) | 112 (10) | NA | NA | 114 (43) | NA |
| Hypertension, No. (%) | 378 (100) | NA | 614 (55) | 227 (45) | 209 (41) | 269 (100) | 784 (42) |
| Diabetes mellitus, No. (%) | 40 (11) | NA | 291 (26) | 100 (20) | 111 (22) | 25 (9) | 211 (11) |
| Heart failure, No. (%) | NA | NA | 361 (32) | 332 (66) | NA | NA | 53 (3) |
| Systolic blood pressure, mmHg | 139±18 | 125±14 | 138±30 | 124±23 | 111±16 | 154±23 | 143±24 |
| Diastolic blood pressure, mmHg | 74±10 | 77±9 | 79±17 | 76±14 | 64±12 | 94±14 | 83±12 |
| Heart rate, beats per minute | 64±10 | 63±9 | 94±25 | 72±16 | 70±13 | 71±11.9 | 74±14 |
| Cholesterol, mmol/L | 5.6±0.89 | 5.7±0.96 | NA | 4.4±1.3 | NA | 5.2±0.98 | 5.4±2.0 |
| Glucose, mmol/L | 5.7±1.5 | 5.1±0.89 | 8.5±4.8 | NA | NA | 5.3±1.4 | 6.0±4.0 |
| Hemoglobin, g/dL | NA | NA | 12.6±1.9 | 13.5±1.8 | NA | 14.1±1.2 | 14.2±1.4 |
| Red blood cell count, 1012 cells/L | NA | NA | NA | NA | NA | 4.8±0.42 | NA |
| White blood cell count, 109 cells/L | NA | NA | 10.0±6.4 | 7.5±2.4 | NA | 6.3±2.2 | NA |
| Platelets, 109 cells/L | NA | NA | NA | NA | NA | 253±65 | NA |
| Creatinine, μmol/L | NA | 84.6±11.9 | 116.2±90.4 | 108.9±66.8 | NA | 83.9±53.2 | 88.7±44.4 |
| BNP, pg/mL | NA | NA | 713 (211–1583) | 493 (315–1750) | NA | NA | NA |
| NT-proBNP, pg/mL | NA | NA | NA | NA | NA | 78 (40–167) | 32 (10–130) |
| Left ventricular mass, g | NA | 162±50 | NA | NA | NA | NA | NA |
| Left ventricular ejection fraction, % | NA | 68±7 | 45±17 | 46±20 | 49±9 | NA | 61±8 |
| Proportion with LVEF <40% | NA | 0 | 198 (37) | 217 (45) | 70 (14) | NA | 43 (3) |
| Proportion with LVEF 40–50% | NA | 0 | 91 (17) | 60 (12) | 193 (38) | NA | 54 (4) |
| Proportion with LVEF >50% | NA | 154 (100) | 246 (46) | 209 (43) | 244 (48) | NA | 1167 (92) |
| E/A ratio | NA | 1.2±0.33 | NA | NA | NA | NA | 1.2±3.3 |
Data are reported as number (%), mean±SD or median (25th–75th) for non-normally distributed variables.
NA: data not available within the cohort